YGR045C Antibody

What is YGR045C and why is it studied in research?

YGR045C is a putative uncharacterized protein from Saccharomyces cerevisiae (strain 204508/S288c), commonly known as Baker's yeast. It is a membrane-associated protein with a predicted single-pass membrane topology . The protein has a molecular weight of approximately 13,645 Da and is encoded by a gene initially considered to be a dubious open reading frame (ORF) . Despite its "uncharacterized" status, studying YGR045C is valuable for several reasons: (1) it contributes to our understanding of yeast proteome and membrane biology, (2) it may have orthologous relationships with proteins in other organisms, and (3) characterizing its function can provide insights into fundamental cellular processes in eukaryotes. Baker's yeast serves as an excellent model organism due to its well-characterized genome and similarity to human cellular mechanisms.

What are the key specifications of commercially available YGR045C antibodies?

Commercially available YGR045C antibodies typically include polyclonal antibodies raised in rabbits against the recombinant Saccharomyces cerevisiae (strain 204508/S288c) YGR045C protein . These antibodies are generally:

• Supplied in liquid format with preservatives (e.g., 0.03% Proclin 300) and stabilizers (50% glycerol in PBS, pH 7.4)

• Non-conjugated (though custom conjugations may be available)

• Purified via antigen-affinity methods

• Validated for applications such as ELISA and Western Blot

• Reactive specifically with Saccharomyces cerevisiae YGR045C

• IgG isotype

• Stored at -20°C or -80°C for maximum shelf-life

The antibodies are generally produced using recombinant full-length protein as the immunogen, optimizing recognition of the native protein structure.

How should YGR045C antibodies be handled and stored to maintain efficacy?

Proper handling and storage of YGR045C antibodies is critical for maintaining their activity and specificity:

What are the validated applications for YGR045C antibodies and their optimal working conditions?

YGR045C antibodies have been validated for several experimental applications, each requiring specific optimization:

• ELISA (Enzyme-Linked Immunosorbent Assay):

  • Typical working dilution: 1:1000 to 1:5000

  • Detection method: Direct or indirect detection systems

  • Controls: Include no-primary antibody, isotype control, and positive control samples

  • Blocking: 3-5% BSA or non-fat milk in PBS or TBS

• Western Blot:

  • Typical working dilution: 1:500 to 1:2000

  • Sample preparation: Denatured protein lysates with appropriate extraction method for membrane proteins

  • Expected band size: Approximately 13.6 kDa

  • Detection: Secondary antibody conjugated to HRP, chemiluminescence, or fluorescence detection

• Immunohistochemistry/Immunofluorescence:

  • Fixation: 4% paraformaldehyde followed by permeabilization for intracellular detection

  • Antigen retrieval: May be necessary depending on fixation method

  • Dilution range: 1:100 to 1:500

  • Incubation: Overnight at 4°C for optimal binding

For each application, optimization through titration experiments is recommended to determine the ideal antibody concentration for specific experimental conditions.

How can researchers validate the specificity of YGR045C antibodies in their experimental systems?

Validating antibody specificity is crucial for reliable research outcomes. For YGR045C antibodies, consider these validation approaches:

• Genetic controls:

  • Use YGR045C knockout yeast strains as negative controls

  • Employ YGR045C overexpression systems as positive controls

  • Compare wild-type and mutant strains in parallel experiments

• Protein-level validation:

  • Perform immunoprecipitation followed by mass spectrometry to confirm target binding

  • Pre-absorb the antibody with recombinant YGR045C protein before immunodetection

  • Include blocking peptides specific to the immunogen region

• Cross-reactivity assessment:

  • Test the antibody against lysates from other yeast species or strains

  • Compare reactivity patterns against predicted molecular weight targets

  • Examine potential cross-reactivity with related proteins using sequence alignment data

• Technical validation:

  • Use multiple antibodies targeting different epitopes of YGR045C

  • Compare monoclonal and polyclonal antibodies for consistent detection patterns

  • Perform reciprocal verification using tagged YGR045C constructs

Documentation of these validation steps strengthens the reliability of research findings and should be included in publications.

What troubleshooting approaches are effective for common problems with YGR045C antibody experiments?

When encountering issues with YGR045C antibody experiments, consider these troubleshooting approaches:

• Weak or no signal in Western blots:

  • Increase antibody concentration or incubation time

  • Optimize protein extraction protocol for membrane proteins

  • Use enhanced detection systems (e.g., high-sensitivity ECL substrates)

  • Check transfer efficiency with reversible protein stains

  • Consider different membrane types (PVDF vs. nitrocellulose)

• High background in immunoassays:

  • Increase blocking concentration (5% BSA or milk)

  • Add 0.1-0.3% Tween-20 to washing buffers

  • Reduce primary and secondary antibody concentrations

  • Pre-absorb antibodies with host species proteins

  • Increase wash frequency and duration

• Inconsistent results between experiments:

  • Standardize protein quantification methods

  • Use internal loading controls consistently

  • Prepare larger antibody aliquots to reduce freeze-thaw cycles

  • Document lot numbers and validate each new antibody lot

  • Control for yeast growth phase and conditions

• Issues in immunoprecipitation:

  • Optimize lysis conditions to preserve protein-protein interactions

  • Use crosslinking approaches for transient interactions

  • Test different bead types and binding conditions

  • Increase antibody amounts for low-abundance targets

Systematic optimization and careful documentation of experimental conditions will help identify and resolve technical issues.

How can YGR045C antibodies be used to study protein-protein interactions in yeast membrane biology?

YGR045C antibodies can be powerful tools for investigating protein-protein interactions and membrane biology in yeast through several advanced approaches:

• Co-immunoprecipitation (Co-IP) studies:

  • Use YGR045C antibodies to capture protein complexes under native conditions

  • Employ gentle lysis buffers containing non-ionic detergents (0.5-1% NP-40 or Triton X-100)

  • Perform sequential immunoprecipitation to identify direct vs. indirect interactions

  • Analyze precipitated complexes via mass spectrometry to identify novel binding partners

• Proximity-dependent labeling approaches:

  • Generate fusion proteins combining YGR045C with BioID or APEX2

  • Use antibodies to confirm expression and localization of fusion constructs

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

• Subcellular fractionation validation:

  • Perform membrane fractionation to isolate different cellular compartments

  • Use YGR045C antibodies to track protein distribution across fractions

  • Compare distribution patterns under different growth conditions or stress responses

• Super-resolution microscopy:

  • Employ YGR045C antibodies with fluorescent secondary antibodies for immunofluorescence

  • Combine with markers for different membrane compartments

  • Use techniques like STORM or PALM to achieve nanometer-scale resolution

  • Quantify co-localization with potential interaction partners

These approaches can reveal functional relationships between YGR045C and other cellular components, potentially elucidating its biological role.

What considerations are important when designing epitope mapping studies for YGR045C antibodies?

Epitope mapping is crucial for understanding antibody binding characteristics and can inform structure-function relationships. When designing epitope mapping studies for YGR045C antibodies:

• Peptide array approaches:

  • Generate overlapping peptides (12-20 amino acids) spanning the entire YGR045C sequence

  • Include both linear and, if possible, conformational epitopes

  • Test antibody binding using ELISA or peptide microarrays

  • Consider different peptide densities and spacing on arrays

• Mutagenesis strategies:

  • Create alanine scanning mutants or deletion constructs

  • Express mutant proteins in yeast or heterologous systems

  • Compare antibody binding to wild-type and mutant proteins

  • Correlate binding changes with specific amino acid positions

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Monitor differential deuterium uptake in the presence/absence of antibody

  • Identify protected regions that likely represent epitope binding sites

  • Combine with computational modeling for structural insights

• Structural analysis considerations:

  • Use available structural prediction tools (e.g., AlphaFold2) for YGR045C

  • Map epitopes onto predicted structures to assess surface accessibility

  • Consider membrane topology when interpreting epitope location

• Cross-reactivity analysis:

  • Test antibody binding to homologous proteins from related yeast species

  • Align sequences to identify conserved versus variable epitope regions

  • Assess whether epitopes correspond to functionally important domains

Comprehensive epitope mapping provides valuable information about antibody specificity and can guide the development of more selective research tools.

How can quantitative analysis of YGR045C be performed using antibody-based approaches?

Quantitative analysis of YGR045C expression levels or modifications requires careful consideration of antibody characteristics and assay design:

• Quantitative Western blotting:

  • Use internal loading controls appropriate for yeast samples

  • Employ fluorescently-labeled secondary antibodies for wider linear range

  • Generate standard curves using recombinant YGR045C protein

  • Use image analysis software with background correction

  • Perform technical and biological replicates for statistical validity

• ELISA-based quantification:

  • Develop sandwich ELISA using capture and detection antibodies targeting different epitopes

  • Generate standard curves with purified recombinant YGR045C

  • Validate assay parameters: limit of detection, dynamic range, precision

  • Include spike-recovery experiments to assess matrix effects

  • Consider competitive ELISA formats for small samples

• Single-cell analysis approaches:

  • Optimize immunofluorescence protocols for quantitative imaging

  • Use automated image analysis to measure signal intensity across populations

  • Employ flow cytometry for high-throughput single-cell quantification

  • Consider microfluidic approaches for time-course studies

• Absolute quantification strategies:

  • Implement selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) mass spectrometry

  • Use stable isotope-labeled peptide standards

  • Validate concordance between antibody-based and MS-based quantification

These approaches enable researchers to move beyond qualitative detection to precise measurement of YGR045C levels under different experimental conditions.

How can YGR045C antibodies be integrated with CRISPR-Cas9 approaches for functional studies?

CRISPR-Cas9 technology offers powerful ways to investigate protein function when combined with antibody detection:

• CRISPR knockout validation:

  • Design guide RNAs targeting the YGR045C gene in yeast

  • Use YGR045C antibodies to confirm complete protein knockout

  • Compare phenotypes between knockout and wild-type strains

  • Reintroduce wild-type or mutant constructs for rescue experiments

• CRISPR knock-in strategies:

  • Create epitope-tagged versions of YGR045C at the endogenous locus

  • Compare detection using YGR045C antibodies versus epitope tag antibodies

  • Generate fluorescent protein fusions for live-cell imaging

  • Create specific point mutations to study structure-function relationships

• CRISPRi/CRISPRa approaches:

  • Use CRISPR interference to downregulate YGR045C expression

  • Use CRISPR activation to upregulate YGR045C

  • Quantify expression changes using YGR045C antibodies

  • Correlate expression levels with phenotypic outcomes

• Temporal control systems:

  • Implement inducible CRISPR systems for time-resolved studies

  • Use YGR045C antibodies to track protein depletion kinetics

  • Monitor downstream effects following YGR045C manipulation

  • Integrate with time-course proteomics or transcriptomics

This integration of genetic manipulation with immunodetection provides a comprehensive approach to understanding YGR045C function.

What approaches can be used to develop and validate custom YGR045C antibodies for specialized applications?

Researchers may need to develop custom antibodies against YGR045C for specialized applications. Key considerations include:

• Antigen design strategies:

  • Select immunogenic regions using epitope prediction algorithms

  • Consider hydrophilicity, surface accessibility, and uniqueness

  • Choose between full-length protein, specific domains, or peptide antigens

  • Avoid transmembrane regions unless specifically targeted

• Expression and purification approaches:

  • Express recombinant YGR045C or fragments in E. coli, yeast, or mammalian systems

  • Optimize purification protocols to maintain native conformation

  • Consider refolding protocols for inclusion body-expressed proteins

  • Validate purity and integrity before immunization

• Antibody generation options:

  • Choose between polyclonal, monoclonal, or recombinant antibody technologies

  • Select appropriate host species based on cross-reactivity concerns

  • Consider phage display for difficult targets or specialized binding properties

  • Evaluate hybridoma versus single B-cell cloning approaches for monoclonals

• Comprehensive validation pipeline:

  • Test antibodies against recombinant protein and endogenous YGR045C

  • Validate in multiple assay formats (Western blot, IP, IF, ELISA)

  • Perform specificity testing using knockout controls

  • Characterize binding parameters (affinity, on/off rates)

For specialized applications like super-resolution microscopy or in vivo imaging, additional validation specific to those techniques should be performed.

How can computational approaches enhance YGR045C antibody-based research?

Computational methods can significantly enhance antibody-based research on YGR045C:

• Structural modeling and epitope prediction:

  • Apply AlphaFold2 or RosettaFold to predict YGR045C structure

  • Use DiscoTope, EPCES, or Ellipro for B-cell epitope prediction

  • Model antibody-antigen interactions using molecular docking

  • Predict effects of mutations on antibody binding

• Systems biology integration:

  • Incorporate antibody-derived protein interaction data into network analyses

  • Integrate transcriptomic data with protein abundance measurements

  • Apply machine learning to identify patterns in multi-omics datasets

  • Model cellular responses to YGR045C perturbation

• Image analysis enhancement:

  • Implement automated segmentation of immunofluorescence images

  • Apply deconvolution algorithms to improve resolution

  • Develop quantitative co-localization metrics

  • Use machine learning for pattern recognition in complex cellular phenotypes

• Antibody sequence analysis:

  • Compare antibody CDR sequences across different anti-YGR045C clones

  • Predict antibody properties from sequence data

  • Apply deep learning models trained on antibody-antigen interactions

  • Design optimized antibody variants in silico

These computational approaches can provide insights that would be difficult to obtain through experimental methods alone and can guide more efficient experimental design.

What quality control metrics should be applied to evaluate YGR045C antibody performance?

Rigorous quality control is essential for reliable antibody-based research. For YGR045C antibodies, implement these key metrics:

• Specificity assessment:

  • Single band detection at expected molecular weight in Western blots

  • Appropriate signal reduction or elimination in knockout/knockdown controls

  • Concordant results using antibodies targeting different epitopes

  • Minimal cross-reactivity with related proteins or in non-target species

• Sensitivity measurements:

  • Determine limit of detection using dilution series of recombinant protein

  • Calculate signal-to-noise ratio across different applications

  • Assess detection capability across various expression levels

  • Compare sensitivity to alternative detection methods

• Reproducibility evaluation:

  • Inter-lot variability assessment using standardized samples

  • Intra-assay and inter-assay coefficient of variation calculation

  • Stability testing under various storage and handling conditions

  • Performance consistency across different experimenters

• Application-specific validation:

  • For ELISA: determine dynamic range, precision, accuracy

  • For Western blot: linearity of signal, loading control correlation

  • For IP: capture efficiency, non-specific binding assessment

  • For immunofluorescence: background levels, signal specificity

Documentation of these metrics should be maintained for each antibody lot and experimental application to ensure data reliability.

How can researchers address cross-reactivity issues with YGR045C antibodies?

Cross-reactivity can compromise experimental results. To address this issue with YGR045C antibodies:

• Preventive strategies:

  • Perform BLAST searches to identify potential cross-reactive proteins

  • Select antibodies raised against unique regions of YGR045C

  • Use antibodies validated in knockout/knockdown systems

  • Consider monoclonal antibodies for improved specificity

• Diagnostic approaches:

  • Test antibody against lysates from YGR045C-deleted strains

  • Perform pre-adsorption tests with recombinant protein

  • Compare detection patterns across different yeast species

  • Use mass spectrometry to identify all proteins in immunoprecipitates

• Mitigation techniques:

  • Implement more stringent washing conditions in immunoassays

  • Optimize blocking to reduce non-specific binding

  • Use competitive binding with soluble antigen to confirm specificity

  • Purify antibodies using antigen-affinity methods

• Reporting and transparency:

  • Document all cross-reactivity testing in publications

  • Acknowledge limitations of antibody specificity

  • Provide detailed methods for antibody validation

  • Share raw data showing complete blots or immunodetection images

Cross-reactivity assessment is particularly important for membrane proteins like YGR045C, which may share structural similarities with other membrane-associated proteins.

What should researchers consider when comparing results from different YGR045C antibody clones or lots?

Comparing results obtained with different antibody clones or lots requires careful consideration:

• Epitope differences:

  • Map binding sites for different antibody clones

  • Consider how epitope location might affect detection of protein variants

  • Assess accessibility of epitopes in different experimental conditions

  • Understand how post-translational modifications might affect epitope recognition

• Technical standardization:

  • Use identical sample preparation methods when comparing antibodies

  • Run side-by-side comparisons on the same blot or plate

  • Implement standard curves using recombinant protein

  • Normalize signals to consistent internal controls

• Clone-specific characteristics:

  • Document isotype differences between antibody clones

  • Consider affinity variations and their impact on detection sensitivity

  • Note differences in optimal working conditions

  • Evaluate batch-to-batch consistency for each clone

• Integrated validation approach:

  • Perform concordance analysis between different antibodies

  • Use orthogonal detection methods to validate observations

  • Consider creating a validation panel of diverse yeast samples

  • Maintain detailed records of performance for each clone and lot

When discrepancies arise between antibodies, additional validation experiments should be conducted to determine which results most accurately reflect the biological reality.

What emerging technologies might enhance YGR045C antibody applications in future research?

Several emerging technologies hold promise for enhancing YGR045C antibody applications:

• Advanced imaging technologies:

  • Super-resolution microscopy techniques like PALM, STORM, and STED

  • Expansion microscopy for improved spatial resolution

  • Lattice light-sheet microscopy for dynamic 3D imaging

  • Correlative light and electron microscopy (CLEM) for ultrastructural context

• Single-molecule approaches:

  • Single-molecule pull-down (SiMPull) for protein complex analysis

  • Single-molecule FRET for conformational studies

  • Super-resolution co-localization analysis

  • DNA-PAINT for multiplexed detection with higher precision

• Antibody engineering innovations:

  • Nanobodies and single-domain antibodies for improved penetration

  • Bispecific antibodies for co-detection of multiple targets

  • Proximity-labeling antibody conjugates

  • Split-antibody complementation systems for interaction studies

• Integrated omics approaches:

  • Spatial proteomics combining antibody detection with mass spectrometry

  • Single-cell proteomics with antibody-based enrichment

  • Microfluidic antibody-based cell sorting linked to sequencing

  • Antibody-guided CRISPR screens

As these technologies mature, they will provide increasingly detailed insights into YGR045C biology and function.

How can data from YGR045C antibody studies be integrated into broader systems biology approaches?

Integrating YGR045C antibody data into systems biology requires thoughtful approaches:

• Multi-omics data integration:

  • Correlate protein abundance data with transcriptomic profiles

  • Integrate protein interaction networks with genetic interaction maps

  • Compare proteomic and phenotypic responses to environmental perturbations

  • Develop computational frameworks for multi-layer data visualization

• Network analysis approaches:

  • Position YGR045C within protein-protein interaction networks

  • Identify pathway enrichment from interaction partners

  • Perform co-expression analysis across conditions

  • Apply graph theory to identify network motifs or modules

• Functional correlation strategies:

  • Link antibody-derived localization data with functional genomics screens

  • Correlate protein abundance with metabolomic changes

  • Perform epistasis analysis with interacting partners

  • Develop predictive models of cellular responses based on YGR045C levels

• Community resource development:

  • Contribute validated antibody data to repositories like Antibodypedia

  • Share standardized protocols through platforms like protocols.io

  • Deposit raw data in appropriate public databases

  • Participate in community standardization efforts

These integrative approaches can transform isolated observations into comprehensive understanding of YGR045C's role in cellular systems.

What are the key considerations for reproducibility and rigor in YGR045C antibody-based research?

Ensuring reproducibility and rigor in antibody-based research requires attention to several key areas:

• Comprehensive antibody documentation:

  • Report complete antibody information: source, catalog number, lot, RRID

  • Document all validation experiments performed

  • Provide detailed experimental protocols including antibody dilutions

  • Share representative images of full blots or immunodetection results

• Appropriate controls implementation:

  • Include positive and negative controls in all experiments

  • Utilize genetic controls (knockouts, knockdowns) whenever possible

  • Implement technical controls (no primary, isotype controls)

  • Perform spike-in experiments to confirm detection specificity

• Quantitative approach to data analysis:

  • Report quantification methods with statistical parameters

  • Include biological and technical replicates in experimental design

  • Perform power analysis to determine appropriate sample sizes

  • Use blinding procedures when applicable for quantitative assessments

• Transparent reporting practices:

  • Acknowledge limitations of antibody-based approaches

  • Report negative or contradictory results

  • Provide access to raw data through repositories

  • Follow field-specific guidelines for antibody research reporting

Adherence to these principles will strengthen the reliability of YGR045C research and contribute to the broader scientific understanding of this protein.